Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
<h4>Introduction</h4>Despite increased treatment availability, HIV-infected individuals continue to start antiretroviral therapy (ART) late in disease progression, increasing early mortality risk.<h4>Materials and methods</h4>Nested prospective cohort study within a randomize...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0223411 |
| _version_ | 1819033211518320640 |
|---|---|
| author | Rachel A Silverman Grace C John-Stewart Ingrid A Beck Ross Milne Catherine Kiptinness Christine J McGrath Barbra A Richardson Bhavna Chohan Samah R Sakr Lisa M Frenkel Michael H Chung |
| author_facet | Rachel A Silverman Grace C John-Stewart Ingrid A Beck Ross Milne Catherine Kiptinness Christine J McGrath Barbra A Richardson Bhavna Chohan Samah R Sakr Lisa M Frenkel Michael H Chung |
| author_sort | Rachel A Silverman |
| collection | DOAJ |
| description | <h4>Introduction</h4>Despite increased treatment availability, HIV-infected individuals continue to start antiretroviral therapy (ART) late in disease progression, increasing early mortality risk.<h4>Materials and methods</h4>Nested prospective cohort study within a randomized clinical trial of adult patients initiating ART at clinics in urban Nairobi and rural Maseno, Kenya, between 2013-2014. We estimated mortality incidence rates following ART initiation and used Cox proportional hazards regression to identify predictors of mortality within 12 months of ART initiation. Analyses were stratified by clinic site to examine differences in mortality correlates and risk by location.<h4>Results</h4>Among 811 participants initiated on ART, the mortality incidence rate within a year of initiating ART was 7.44 per 100 person-years (95% CI 5.71, 9.69). Among 207 Maseno and 612 Nairobi participants initiated on ART, the mortality incidence rates (per 100 person-years) were 12.78 (95% CI 8.49, 19.23) and 5.72 (95% CI 4.05, 8.09). Maseno had a 2.20-fold greater risk of mortality than Nairobi (95% CI 1.29, 3.76; P = 0.004). This association remained [adjusted hazard ratio (HR) = 2.09 (95% CI 1.17, 3.74); P = 0.013] when adjusting for age, gender, education, pre-treatment drug resistance (PDR), and CD4 count, but not when adjusting for BMI. In unadjusted analyses, other predictors (P<0.05) of mortality included male gender (HR = 1.74), age (HR = 1.04 for 1-year increase), fewer years of education (HR = 0.92 for 1-year increase), unemployment (HR = 1.89), low body mass index (BMI<18.5 m/kg2; HR = 4.99), CD4 count <100 (HR = 11.67) and 100-199 (HR = 3.40) vs. 200-350 cells/μL, and pre-treatment drug resistance (PDR; HR = 2.49). The increased mortality risk associated with older age, males, and greater education remained when adjusted for location, age, education and PDR, but not when adjusted for BMI and CD4 count. PDR remained associated with increased mortality risk when adjusted for location, age, gender, education, and BMI, but not when adjusted for CD4 count. CD4 and BMI associations with increased mortality risk persisted in multivariable analyses. Despite similar baseline CD4 counts across locations, mortality risk associated with low CD4 count, low BMI, and PDR was greater in Maseno than Nairobi in stratified analyses.<h4>Conclusions</h4>High short-term post-ART mortality was observed, partially due to low CD4 count and BMI at presentation, especially in the rural setting. Male gender, older age, and markers of lower socioeconomic status were also associated with greater mortality risk. Engaging patients earlier in HIV infection remains critical. PDR may influence short-term mortality and further studies to optimize management will be important in settings with increasing PDR. |
| first_indexed | 2024-12-21T07:14:14Z |
| format | Article |
| id | doaj.art-698ec9d337fc4b399368fe4c7870c9e3 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T07:14:14Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-698ec9d337fc4b399368fe4c7870c9e32022-12-21T19:11:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022341110.1371/journal.pone.0223411Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.Rachel A SilvermanGrace C John-StewartIngrid A BeckRoss MilneCatherine KiptinnessChristine J McGrathBarbra A RichardsonBhavna ChohanSamah R SakrLisa M FrenkelMichael H Chung<h4>Introduction</h4>Despite increased treatment availability, HIV-infected individuals continue to start antiretroviral therapy (ART) late in disease progression, increasing early mortality risk.<h4>Materials and methods</h4>Nested prospective cohort study within a randomized clinical trial of adult patients initiating ART at clinics in urban Nairobi and rural Maseno, Kenya, between 2013-2014. We estimated mortality incidence rates following ART initiation and used Cox proportional hazards regression to identify predictors of mortality within 12 months of ART initiation. Analyses were stratified by clinic site to examine differences in mortality correlates and risk by location.<h4>Results</h4>Among 811 participants initiated on ART, the mortality incidence rate within a year of initiating ART was 7.44 per 100 person-years (95% CI 5.71, 9.69). Among 207 Maseno and 612 Nairobi participants initiated on ART, the mortality incidence rates (per 100 person-years) were 12.78 (95% CI 8.49, 19.23) and 5.72 (95% CI 4.05, 8.09). Maseno had a 2.20-fold greater risk of mortality than Nairobi (95% CI 1.29, 3.76; P = 0.004). This association remained [adjusted hazard ratio (HR) = 2.09 (95% CI 1.17, 3.74); P = 0.013] when adjusting for age, gender, education, pre-treatment drug resistance (PDR), and CD4 count, but not when adjusting for BMI. In unadjusted analyses, other predictors (P<0.05) of mortality included male gender (HR = 1.74), age (HR = 1.04 for 1-year increase), fewer years of education (HR = 0.92 for 1-year increase), unemployment (HR = 1.89), low body mass index (BMI<18.5 m/kg2; HR = 4.99), CD4 count <100 (HR = 11.67) and 100-199 (HR = 3.40) vs. 200-350 cells/μL, and pre-treatment drug resistance (PDR; HR = 2.49). The increased mortality risk associated with older age, males, and greater education remained when adjusted for location, age, education and PDR, but not when adjusted for BMI and CD4 count. PDR remained associated with increased mortality risk when adjusted for location, age, gender, education, and BMI, but not when adjusted for CD4 count. CD4 and BMI associations with increased mortality risk persisted in multivariable analyses. Despite similar baseline CD4 counts across locations, mortality risk associated with low CD4 count, low BMI, and PDR was greater in Maseno than Nairobi in stratified analyses.<h4>Conclusions</h4>High short-term post-ART mortality was observed, partially due to low CD4 count and BMI at presentation, especially in the rural setting. Male gender, older age, and markers of lower socioeconomic status were also associated with greater mortality risk. Engaging patients earlier in HIV infection remains critical. PDR may influence short-term mortality and further studies to optimize management will be important in settings with increasing PDR.https://doi.org/10.1371/journal.pone.0223411 |
| spellingShingle | Rachel A Silverman Grace C John-Stewart Ingrid A Beck Ross Milne Catherine Kiptinness Christine J McGrath Barbra A Richardson Bhavna Chohan Samah R Sakr Lisa M Frenkel Michael H Chung Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. PLoS ONE |
| title | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. |
| title_full | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. |
| title_fullStr | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. |
| title_full_unstemmed | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. |
| title_short | Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study. |
| title_sort | predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural kenya a prospective cohort study |
| url | https://doi.org/10.1371/journal.pone.0223411 |
| work_keys_str_mv | AT rachelasilverman predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT gracecjohnstewart predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT ingridabeck predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT rossmilne predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT catherinekiptinness predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT christinejmcgrath predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT barbraarichardson predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT bhavnachohan predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT samahrsakr predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT lisamfrenkel predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy AT michaelhchung predictorsofmortalitywithinthefirstyearofinitiatingantiretroviraltherapyinurbanandruralkenyaaprospectivecohortstudy |